Exane Derivatives’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$533K Sell
3,705
-145
-4% -$20.8K 0.31% 78
2022
Q1
$588K Sell
3,850
-440
-10% -$67.2K 0.17% 167
2021
Q4
$702K Sell
4,290
-500
-10% -$81.8K 0.17% 136
2021
Q3
$670K Sell
4,790
-572
-11% -$80K 0.16% 133
2021
Q2
$734K Sell
5,362
-656
-11% -$89.9K 0.17% 117
2021
Q1
$815K Sell
6,018
-2,356
-28% -$319K 0.23% 90
2020
Q4
$1.17M Buy
8,374
+1,351
+19% +$188K 0.34% 61
2020
Q3
$976K Buy
7,023
+1,562
+29% +$217K 0.28% 79
2020
Q2
$653K Buy
5,461
+1,334
+32% +$160K 0.17% 99
2020
Q1
$454K Sell
4,127
-5,315
-56% -$585K 0.13% 121
2019
Q4
$1.19M Buy
9,442
+7,380
+358% +$929K 0.22% 95
2019
Q3
$256K Sell
2,062
-5,684
-73% -$707K 0.05% 203
2019
Q2
$849K Sell
7,746
-918
-11% -$101K 0.15% 105
2019
Q1
$901K Sell
8,664
-46,083
-84% -$4.79M 0.18% 117
2018
Q4
$5.03M Buy
54,747
+42,092
+333% +$3.87M 0.9% 11
2018
Q3
$1.05M Buy
+12,655
New +$1.05M 0.2% 101
2016
Q4
Sell
-8,597
Closed -$772K 618
2016
Q3
$772K Sell
8,597
-5,251
-38% -$471K 0.12% 107
2016
Q2
$1.17M Buy
13,848
+4,447
+47% +$377K 0.19% 80
2016
Q1
$774K Buy
9,401
+270
+3% +$22.2K 0.1% 93
2015
Q4
$725K Sell
9,131
-3,242
-26% -$257K 0.1% 84
2015
Q3
$890K Buy
12,373
+1,400
+13% +$101K 0.11% 80
2015
Q2
$858K Buy
10,973
+49
+0.4% +$3.83K 0.09% 88
2015
Q1
$895K Buy
10,924
+2,951
+37% +$242K 0.1% 90
2014
Q4
$726K Buy
+7,973
New +$726K 0.1% 102